Peptide Comparisons
Head-to-Head
Peptide Analysis
Side-by-side breakdowns of the most-compared research peptide pairs. Mechanism, half-life, dosing, research evidence, and stack compatibility — everything you need to choose the right compound for your research goals.
Mechanism-First Analysis
Each comparison starts with receptor biology and downstream signaling — so you understand why two peptides differ, not just that they do.
Research Goal Matching
Every head-to-head concludes with a 'Best For' recommendation tied to specific research endpoints, not vague generalizations.
Evidence-Graded Claims
Claims are graded by preclinical vs clinical evidence. We distinguish rodent data from human trial data throughout every comparison.
BPC-157 vs TB-500
The ultimate recovery peptide showdown
Research Verdict
BPC-157 excels at gut lining repair and tendon attachment-site healing with local injection precision. TB-500 (Thymosin Beta-4 fragment) distributes systemically, making it superior for multi-site injuries and muscle fiber repair. Most research protocols combine both for synergistic benefit.
BPC-157 — Key Strengths
- Superior for gut, intestinal, and mucosal healing
- Precise local injection targeting
- Upregulates VEGF and EGR-1 growth factors
- Oral bioavailability documented in gut research
- Strong anti-inflammatory COX-2 modulation
TB-500 — Key Strengths
- Systemic distribution reaches all tissue compartments
- Longer half-life supports less frequent dosing
- Superior for diffuse multi-site muscle damage
- Promotes cell migration and wound closure
- Used in cardiac tissue repair research
Best For — BPC-157
Gut issues, localized tendon injuries, post-surgical recovery
Best For — TB-500
Systemic recovery, multi-site injuries, cardiac & muscle tissue
Ipamorelin vs GHRP-2
Clean GH pulse vs maximum GH output
Research Verdict
Ipamorelin is the cleaner, side-effect-friendly GH secretagogue — it raises GH with minimal cortisol or prolactin bleed. GHRP-2 produces a larger, broader GH pulse but comes with more pronounced hunger stimulation and cortisol elevation. For long-term research protocols, Ipamorelin is generally preferred; GHRP-2 is used when maximum GH amplitude is the research goal.
Ipamorelin — Key Strengths
- Highly selective — GH only, no cortisol/prolactin bleed
- Best-in-class stack partner for CJC-1295 protocols
- Minimal hunger side effects
- Well-tolerated in long-term research cycles
- Ideal for sleep-time GH pulse research
GHRP-2 — Key Strengths
- Larger GH amplitude — useful for maximum pulse research
- More potent anabolic signaling at higher doses
- Appetite stimulation useful in cachexia research
- Well-documented in rodent and human GHSR studies
Best For — Ipamorelin
Long-term anti-aging and GH optimization protocols
Best For — GHRP-2
Short-term maximum GH output research
Tirzepatide vs Retatrutide
Dual agonist vs triple agonist metabolic research
Research Verdict
Tirzepatide (GIP/GLP-1 dual agonist) is the most clinically validated dual-incretin peptide with extensive human trial data. Retatrutide adds glucagon receptor agonism as a third target (GIP/GLP-1/GCGR), producing greater mean weight loss in Phase 2 trials but with a less mature safety dataset. For documented metabolic research, Tirzepatide is the reference standard; Retatrutide is the frontier.
Tirzepatide — Key Strengths
- Largest and most replicated human trial dataset
- Proven cardiovascular risk reduction data
- Established dose-titration protocols
- Best documented GLP-1 + GIP synergy
- Preferred standard for metabolic research comparison
Retatrutide — Key Strengths
- Superior mean weight loss in head-to-head models
- Triple-receptor mechanism for broader metabolic targeting
- Greater hepatic fat clearance via glucagon arm
- Better lean mass preservation at similar weight loss
- Next-generation metabolic research frontier
Best For — Tirzepatide
Established metabolic research, insulin sensitivity, cardiovascular endpoints
Best For — Retatrutide
Maximum fat loss, hepatic steatosis, novel triple-agonist mechanism research
CJC-1295 vs Sermorelin
Long-acting GHRH analog vs natural GHRH fragment
Research Verdict
CJC-1295 with DAC binds albumin in the bloodstream, extending its half-life to 6–8 days and creating a sustained GH pulse elevation throughout the week. Sermorelin mimics the natural 1-29 fragment of GHRH with a short 10–20 minute half-life, producing pulsatile GH release that more closely mirrors natural physiology. Sermorelin is considered the 'gentler' choice; CJC-1295 DAC is preferred for sustained GH elevation.
CJC-1295 (DAC) — Key Strengths
- Infrequent dosing (1–2× per week) — high compliance
- Sustained IGF-1 elevation for anabolic research
- DAC linkage provides exceptional stability
- High-amplitude GH pulse potential
Sermorelin — Key Strengths
- Most physiologically accurate GHRH mimetic
- Lower risk of pituitary desensitization
- Gentler profile suited for anti-aging longevity research
- Lower chance of GH bleed side effects
- Preferred starting point for first-time GH axis research
Best For — CJC-1295 (DAC)
Convenience-focused GH optimization, high-IGF-1 anabolic protocols
Best For — Sermorelin
Physiologically accurate GHRH research, longevity and anti-aging protocols
Epithalon vs GHK-Cu
Telomere longevity vs collagen-copper anti-aging
Research Verdict
Epithalon (Epitalon) operates through telomerase activation and pineal gland regulation, addressing aging at the cellular/genetic level. GHK-Cu works through copper complex signaling to upregulate collagen synthesis, skin repair, and wound healing with significant effects on skin and connective tissue. Both are cornerstone longevity peptides with complementary — not competing — mechanisms.
Epithalon — Key Strengths
- Only well-studied telomerase-activating peptide
- Pineal bioregulator — melatonin and sleep regulation
- Significant mortality reduction in rodent longevity studies
- Combined with MOTS-c for mitochondrial longevity stack
- Addresses root cause of cellular aging
GHK-Cu — Key Strengths
- One of the most studied repair peptides (1,000+ publications)
- Topical delivery for cosmetic and dermal research
- Direct collagen I, III, and VII gene upregulation
- Anti-inflammatory via NFkB pathway modulation
- Wound healing, nerve regeneration, and hair follicle research
Best For — Epithalon
Cellular longevity, telomere biology, sleep optimization, systemic anti-aging
Best For — GHK-Cu
Skin repair, wound healing, topical anti-aging, collagen synthesis
Decision Framework
How to Choose Between Peptides
The right peptide for a research protocol depends on four factors. Work through this framework before committing to a compound.
Define the Research Endpoint
What biological outcome is being studied? Tendon repair, GH axis stimulation, metabolic regulation, and telomere biology each require different peptide classes. A recovery peptide will not meaningfully impact GH secretion, and vice versa.
Match Mechanism to Target
Read the receptor binding profile of each candidate. BPC-157 works through VEGF and growth factor upregulation; TB-500 through actin polymerization. Same category, completely different mechanisms — and different tissue targets as a result.
Consider Half-life and Protocol Fit
CJC-1295 DAC's 6–8 day half-life enables weekly dosing while Sermorelin requires daily injections. The right half-life depends on whether continuous or pulsatile signaling matches your research model.
Check Stack Compatibility
Many peptides show synergistic effects when combined — BPC-157 + TB-500 for recovery, Ipamorelin + CJC-1295 for GH stimulation. Check whether candidates share complementary or competing pathways before designing a multi-peptide protocol.
Commonly Researched Combinations
Peptide pairs and stacks with documented synergistic research rationale
Recovery & Repair
BPC-157 handles localized tendon and gut repair via VEGF; TB-500 provides systemic tissue distribution via actin polymerization. Complementary — not redundant.
GH Optimization
Ipamorelin triggers GH release from somatotroph cells; CJC-1295 amplifies GHRH signaling. Combined pulse is significantly larger than either alone.
Anti-Aging
Epithalon works at the telomere/telomerase level; GHK-Cu works at the extracellular matrix and gene expression level. Complementary longevity mechanisms.
Weight Loss
Tirzepatide drives appetite and incretin regulation; AOD9604 acts on fat cell lipolysis directly. Potential for additive fat loss via different pathways.
Cognitive & Anxiolytic
Semax upregulates BDNF for neuroplasticity; Selank modulates the GABAergic and serotonergic systems for anxiolytic effects. Cognitive + mood complementarity.
Research Use Only
All comparisons on this page are for educational and research purposes. These compounds are not approved for human therapeutic use. No comparison constitutes medical advice. Consult a qualified physician and review applicable regulations before any research use.
Ready to Research?
Source Research-Grade Peptides
All peptides reviewed on this page are available from Phiogen with COA documentation, ≥99% purity verification, and independent HPLC testing.